M3C Stock Chart & Stats
€5.20
-€0.16(-3.30%)
At close: 4:00 PM EST
€5.20
-€0.16(-3.30%)
Day’s Range― - ―
52-Week Range€4.30 - €6.50
Previous CloseN/A
Volume0.00
Average Volume (3M)10.00
Market Cap
€8.66B
Enterprise Value€3.38M
Total Cash (Recent Filing)€527.10B
Total Debt (Recent Filing)€1.89T
Price to Earnings (P/E)―
Beta0.64
Next Earnings
Jul 31, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-60.68
Shares Outstanding1,441,467,200
10 Day Avg. Volume0
30 Day Avg. Volume10
Financial Highlights & Ratios
PEG Ratio-1.43
Price to Book (P/B)0.70
Price to Sales (P/S)0.33
P/FCF Ratio8.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€6.85Price Target Upside31.66% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)0.47
Revenue Forecast (FY)€21.35B
Bulls Say, Bears Say
Bulls Say
Resilient Cash GenerationConsistent operating cash flow and recurring positive free cash flow provide a durable funding source for capex, dividends, and debt reduction. This cash-generation resilience cushions cyclical revenue swings and supports strategic reinvestment in higher‑margin specialty businesses over the next several months.
Diversified End MarketsBroad exposure across automotive, electronics, healthcare, packaging and industrial markets reduces reliance on any single cyclical sector. This structural diversification spreads demand risk and supports steadier order flows and long‑run customer relationships, improving revenue stability over a 2–6 month horizon.
Higher-value Specialty Materials And Life SciencesA meaningful portfolio of performance and specialty products and life‑science offerings supports differentiated revenue streams with better margin potential and long customer contracts. These structural advantages enable pricing power and stickier demand versus commodity chemicals, aiding margin recovery as markets normalize.
Bears Say
Profitability DeteriorationA sharp decline to near‑zero net margin indicates damaged earnings quality and limited buffer against shocks. Even with some positive EBITDA margins, the collapse at the bottom line reduces retained earnings, limits reinvestment, and makes sustainable profit recovery dependent on structural cost or mix improvements.
Volatile And Declining RevenueMaterial top‑line volatility and recent annual declines complicate planning and weaken scale economics. Persistent revenue weakness constrains margin leverage and investment capacity, making turnaround dependent on sustained demand recovery or successful portfolio shifts toward higher‑value products.
Elevated Leverage And Weak ROEDebt roughly in line with equity and a collapsing ROE reduce financial flexibility and raise interest sensitivity. Elevated leverage limits ability to invest or pursue M&A without further deleveraging, and near‑zero ROE signals poor capital efficiency that can constrain shareholder returns and strategic options.
Mitsubishi Chemical Holdings News
M3C FAQ
What was Mitsubishi Chemical Holdings’s price range in the past 12 months?
Mitsubishi Chemical Holdings lowest stock price was €4.30 and its highest was €6.50 in the past 12 months.
What is Mitsubishi Chemical Holdings’s market cap?
Mitsubishi Chemical Holdings’s market cap is €8.66B.
When is Mitsubishi Chemical Holdings’s upcoming earnings report date?
Mitsubishi Chemical Holdings’s upcoming earnings report date is Jul 31, 2026 which is in 4 days.
How were Mitsubishi Chemical Holdings’s earnings last quarter?
Mitsubishi Chemical Holdings released its earnings results on May 13, 2026. The company reported -€0.365 earnings per share for the quarter, missing the consensus estimate of -€0.208 by -€0.157.
Is Mitsubishi Chemical Holdings overvalued?
According to Wall Street analysts Mitsubishi Chemical Holdings’s price is currently Undervalued.
Does Mitsubishi Chemical Holdings pay dividends?
Mitsubishi Chemical Holdings does not currently pay dividends.
What is Mitsubishi Chemical Holdings’s EPS estimate?
Mitsubishi Chemical Holdings’s EPS estimate is 0.1.
How many shares outstanding does Mitsubishi Chemical Holdings have?
Mitsubishi Chemical Holdings has 1,441,467,200 shares outstanding.
What happened to Mitsubishi Chemical Holdings’s price movement after its last earnings report?
Mitsubishi Chemical Holdings reported an EPS of -€0.365 in its last earnings report, missing expectations of -€0.208. Following the earnings report the stock price went up 13.79%.
Which hedge fund is a major shareholder of Mitsubishi Chemical Holdings?
Currently, no hedge funds are holding shares in DE:M3C
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mitsubishi Chemical Holdings
Established in 2005 and headquartered in Tokyo, Japan, Mitsubishi Chemical Group Corporation operates globally, offering a vast array of products and specialized services. The company's diverse portfolio includes advanced performance materials, fundamental chemicals, industrial gases, and a comprehensive suite of healthcare solutions. Its performance materials segment features specialty chemicals, functional food ingredients, inorganic compounds, electronic and electrical components, molded and processed goods, various films and sheets, synthetic and carbon fibers, alongside a wide range of equipment and systems. This division also provides materials for industrial applications, construction, civil engineering, and water-related projects, as well as consumer goods for leisure, sports, and everyday use. Within the healthcare sector, the corporation delivers pharmaceuticals, drug formulation substances, and innovative drug discovery solutions. It also supplies diagnostic reagents, medical instruments, and offers extensive support services spanning medical care, nursing assistance, general health support, and clinical examinations. Furthermore, Mitsubishi Chemical Group provides essential industrial materials like basic chemicals, carbon products, synthetic resins, and a variety of industrial gases. Complementing its product offerings, the company's service capabilities are robust, covering engineering, information technology, analysis, inspection, packaging, logistics, surveying, consulting, transportation, and warehousing.
M3C Company Deck
M3C Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed performance. Highlights included strong cost management and performance in industrial gases and healthcare. However, significant challenges were noted in specialty and basic materials, as well as ongoing struggles in the MMA and carbon businesses.View all DE:M3C earnings summariesM3C Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€6.85
▲(31.66% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Asahi Kasei
―
Shin-Etsu Chemical Co
―
Resonac Holdings Corporation
―
Sumitomo Chemical Co
―
Tosoh
―










